CDKN2A and astrocytoma (excluding glioblastoma): It should be noted that CDKN2A/B homozygous deletions is a strong indicator for poor prognosis and has been distinguished from Glioblastoma to be categorized as IDH-mutant astrocytoma: astrocytoma, IDH-mutant, CNS WHO grade IV (45).